Gyroscope Capital Management Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $4.65M | Buy |
80,036
+9,024
| +13% | +$524K | 1.07% | 29 |
|
|
2023
Q2 | $4.54M | Buy |
71,012
+2,258
| +3% | +$144K | 1.05% | 32 |
|
|
2023
Q1 | $4.77M | Buy |
68,754
+1,997
| +3% | +$138K | 1.21% | 29 |
|
|
2022
Q4 | $4.8M | Sell |
66,757
-1,465
| -2% | -$105K | 1.46% | 27 |
|
|
2022
Q3 | $4.85M | Sell |
68,222
-210
| -0.3% | -$14.9K | 1.87% | 24 |
|
|
2022
Q2 | $5.27M | Sell |
68,432
-544
| -0.8% | -$41.9K | 1.81% | 27 |
|
|
2022
Q1 | $5.04M | Sell |
68,976
-116,147
| -63% | -$8.48M | 1.73% | 25 |
|
|
2021
Q4 | $11.5M | Buy |
185,123
+12,981
| +8% | +$809K | 4.06% | 2 |
|
|
2021
Q3 | $10.2M | Buy |
172,142
+2,202
| +1% | +$130K | 3.85% | 3 |
|
|
2021
Q2 | $11.4M | Buy |
169,940
+1,174
| +0.7% | +$78.4K | 3.99% | 3 |
|
|
2021
Q1 | $10.7M | Buy |
168,766
+6,046
| +4% | +$382K | 4.26% | 1 |
|
|
2020
Q4 | $10.1M | Sell |
162,720
-3,391
| -2% | -$210K | 4.34% | 2 |
|
|
2020
Q3 | $10M | Sell |
166,111
-72,548
| -30% | -$4.37M | 4.54% | 1 |
|
|
2020
Q2 | $14M | Sell |
238,659
-43,593
| -15% | -$2.56M | 6.37% | 1 |
|
|
2020
Q1 | $15.7M | Sell |
282,252
-2,705
| -0.9% | -$151K | 7.4% | 1 |
|
|
2019
Q4 | $18.3M | Buy |
284,957
+134,937
| +90% | +$8.66M | 6.6% | 1 |
|
|
2019
Q3 | $7.43M | Sell |
150,020
-6,046
| -4% | -$300K | 2.95% | 11 |
|
|
2019
Q2 | $7.16M | Buy |
156,066
+2,310
| +2% | +$106K | 2.7% | 20 |
|
|
2019
Q1 | $7.15M | Buy |
153,756
+6,651
| +5% | +$309K | 2.73% | 18 |
|
|
2018
Q4 | $7.65M | Buy |
+147,105
| New | +$7.65M | 2.92% | 4 |
|